Your Partner in Drug Delivery implants and Devices

PreclinApps is known for cost-efficient sustained-release drug delivery devices for preclinical research

We focus on the development, consulting, and commercialization of sustained-release products and services for preclinical drug discovery, veterinary medicine, and selected clinical applications. Our implantable MedRod® drug delivery technology is widely used for chronic dosing in preclinical animal research, enabling precise and controlled administration of hormones as well as investigational drugs

Innovative Tools For Drug Delivery

Drug Delivery Systems

MedRod® implants for in vivo research help you to implement 3R ethical principles in your laboratory and animal research. MedRod implants enable the chronic dosing of your drug in a very stable manner and thus will ensure the quality of your studies and efficient use of animals. MedRod system doses just the drug, nothing else to the target animal or tissue. No dissolving excipients are used in our system.

“Our broad expertise in drug development, formulation development, preclinical and medical R&D help you to develop high quality polymer-based drug delivery systems for clinical, veterinary and preclinical applications.”

Jukka Rissanen
CEO

What We provide

Do you know the drug release rate of your delivery system in use? Is it based on assumption or real measurements?

Drug release
PreclinApps provides drug delivery solutions to improve and control the release rates of your drug compound. By providing us your molecule of interest and desired drug release rate and we will give you our solution to deliver your molecule safely and steadily.
MedRod® implants designed for preclinical animal research.

Implants have been designed especially for supplementing tumor growth in hormone dependent cancer xenograft and PDX studies.

Contract Research Organization

PreclinApps can also serve as a contract research organization (CRO) and provide R&D services for pharmaceutical industry and other research institutes.

Consulting

PreclinApps can aid your research by guiding in the selection of animal model with suitable polymer and dosage selection. PreclinApps has decades of experience in animal research. We can also help you in designing long-term drug delivery systems for human use, including the material selection process and early feasibility studies including test sample manufacturing and dissolution studies.

Clients and collaborators

Working with The Best

The Team

Management Team and CO-Founders

Jukka Rissanen

CEO, BOARD MEMBER, CO-FOUNDER
Harri Jukarainen

Harri Jukarainen

TECHNOLOGY DIRECTOR, BOARD MEMBER, CO-FOUNDER

Saku Ruohonen

SCIENTIFIC DIRECTOR, CHAIRMAN OF THE BOARD, CO-FOUNDER